Interestingly, in this same study, serum GFAP levels followed a dose–response relationship where GFAP increased from cognitively unimpaired without T2D, to T2D only, to cognitively impaired only, and finally to T2D with cognitive impairment, suggesting that the presence of T2D confers added neuroimmune stress above and beyond that which underlies general cognitive impairment. Here, GFAP is linked to type 2 diabetes mellitus.